Predicting Outcomes of GPOEM Using Gastric Electrical Mapping - Trial NCT06381349
Access comprehensive clinical trial information for NCT06381349 through Pure Global AI's free database. This phase not specified trial is sponsored by Chris Varghese and is currently Not yet recruiting. The study focuses on Gastroparesis. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chris Varghese
University of Auckland, New Zealand
Timeline & Enrollment
N/A
May 01, 2024
Jun 01, 2026
Primary Outcome
Gastroparesis Cardinal Symptom Index (GCSI)
Summary
Gastric peroral endoscopic myotomy (GPOEM) is a minimally-invasive procedure that involves
 dividing the pylorus, to enhance gastric emptying in gastroparesis patients. This is a
 single-arm, multi-centre, prospective observational study to determine the clinical utility
 of Gastric Alimetry in predicting GPOEM treatment outcomes. The investigators further aim to
 develop a clinical decision rule to inform patient selection. Gastric Alimetry will be
 conducted 1 month prior to GPOEM. All subjects will then be followed up for 12 months.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06381349
Non-Device Trial